Vibrato Medical is starting prospective clinical trials in patients with advanced Peripheral Arterial Disease (PAD) and Critical Limb Ischemia (CLI). The overall objective of the study is to determine if Vibrato’s technology is safe and effective for advanced PAD and CLI patients.
If you are interested to participate in the trial or want to know more, please contact us.
This research is supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R44HL156543. The content is solely the responsibility of Vibrato Medical and does not necessarily represent the official views of the National Institutes of Health. The research is conducted following Financial Conflict of Interest (FCOI) policy that can be found here.